B3GAT2 and liver disorder: Glycerophospholipid, as one of the constituents of the cell membrane, participates in the recognition and signal transduction of the cell membrane to the protein and affects drug phase I metabolic enzyme cytochrome P450s and phase II metabolic enzyme UDP-glucuronosyltransferase, aggravating metabolite disorder and leading to liver disease (Stingl et al., 2014).